Alexion is a global biopharmaceutical company dedicated to transforming the lives of individuals living with rare disorders. With a strong focus on innovation, Alexion develops life-changing therapies that address the unique needs of the rare disease community. The company's dedication to rare diseases is evident in their motto: Alexion Rare is Many.

Rare is Strong. Rare is Proud. They strive to tackle health inequities faced by the rare disease community, as highlighted by their CEO.

Alexion offers a range of support services for patients and families impacted by rare diseases. They provide medications for conditions like aHUS, gMG, HPP, LAL-D, NMOSD, and PNH, empowering patients to live their best lives. The company's commitment extends beyond providing treatments.

They actively engage in research and development, forging partnerships to drive scientific advancements. Corporate social responsibility is central to their mission, exemplified by the Alexion Charitable Foundation and managed access programs. Through their relentless pursuit of breakthroughs, Alexion is inspired by the stories of individuals living with rare diseases.

With a global presence and a dedicated team of professionals, they are driven to make a meaningful difference in the lives of patients and families worldwide